Mitchell H. Gold
2020
In 2020, Mitchell H. Gold earned a total compensation of $1.4M as Executive Chairman and Chief Executive Officer at Nivalis Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $317,500 |
|---|---|
| Option Awards | $566,512 |
| Salary | $500,000 |
| Total | $1,384,012 |
Gold received $566.5K in option awards, accounting for 41% of the total pay in 2020.
Gold also received $317.5K in non-equity incentive plan and $500K in salary.
Rankings
In 2020, Mitchell H. Gold's compensation ranked 7,204th out of 13,090 executives tracked by ExecPay. In other words, Gold earned more than 45.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,204 out of 13,090 | 45th |
Division Manufacturing | 3,013 out of 5,621 | 46th |
Major group Chemicals And Allied Products | 1,217 out of 2,254 | 46th |
Industry group Drugs | 1,050 out of 1,954 | 46th |
Industry Pharmaceutical Preparations | 784 out of 1,459 | 46th |
Source: SEC filing on April 29, 2022.
Gold's colleagues
We found two more compensation records of executives who worked with Mitchell H. Gold at Nivalis Therapeutics in 2020.